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Abstract 
Background: Streptococcus pneumoniae is an intermittent commensal organism in 
the nasopharynx. Colonisation is a prerequisite for disease and malnourished 
children are especially susceptible to severe infection. This systematic review 
examines published prevalence rates of pneumococcal colonisation in the upper 
respiratory tract of chronically malnourished children under the age of five years. 
  
Methods: A systematic literature search was performed using Medline, PubMed, 
Web of Science and Scopus. After screening, relevant studies were assessed for 
quality using STROBE criteria. Colonisation data were extracted and a random-
effects model used to pool prevalence estimates. 
  
Findings: Nine studies were included. The prevalence rate of S. pneumoniae 
colonisation in malnourished children during the first month of life ranged from 1.0-
2.0% increasing at 2 months to 53.9-80.0%. Carriage remained similar from 3 
months to 60 months at 64.1-88.0%. Meta-analysis showed a pooled prevalence of 
67.2% in 0-3 months infants (95% CI, 55.6-78.7%), 77.9% in 3-6 months infants 
(95% CI, 68.1-87.7%) and 77.8% in 6-60 months infants (95% CI, 73.9-81.6%). 
  
Conclusion: In malnourished children, it is plausible that rates of pneumococcal 
colonisation are higher than in healthy, well-nourished children. Knowledge of 
colonisation rates can inform policies on vaccination and ancillary interventions 
during treatment of malnutrition. Future studies should assess the impact of reducing 
colonisation on disease rates or transmission in these “at risk” individuals. 
 
Keywords: CARRIER STATE, COLONISATION, MALNUTRITION, 
STREPTOCOCCUS PNEUMONIAE, UPPER RESPIRATORY TRACT 
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Introduction 
Streptococcus pneumoniae (S. pneumoniae) is a leading global cause of respiratory-
tract infections and invasive disease in young children, the elderly and 
immunocompromised patients. In 2015, pneumonia accounted for 16% of all deaths 
of children less than five years of age.1 Immunisation programmes using 
pneumococcal conjugate vaccines (PCV) and polysaccharide vaccines (PPV) reduce 
colonisation rates and mortality from invasive disease in a serotype-specific manner.2 
Their utility in Low and Middle Income Countries (LMIC) can be limited by cost, 
variable coverage of locally circulating serotypes,3 and the high frequency of 
individuals with medical conditions that alter their immune responses (such as 
malnutrition or HIV4). 
 
The upper respiratory tract (URT) provides an ecological niche for diverse bacterial 
populations and S. pneumoniae frequently but asymptomatically colonises the URT, 
especially in young children.5 Progression to mucosal disease (such as sinusitis, 
otitis media and pneumonia) and invasive pneumococcal disease (IPD) can occur if 
immunological and mechanical defences are breached and such events are more 
likely amongst individuals with higher colonisation rates.6 Nasopharyngeal 
aerosolization of S. pneumoniae is considered the primary mode of population 
transmission.7 The high rates of S. pneumoniae colonisation seen in the under 5s 
partly explain the more frequent disease in this age group and why children are 
thought to be the main reservoir and vector of spread.8 
 
Young children also have incomplete protection against disease due to immature 
adaptive and innate immunity.9 These systems actively sense colonising mucosal 
bacteria and maintain a balanced regulatory environment.10 Higher disease 
prevalence in LMICs reflects a variety of environmental challenges such as over-
crowding, particulate exposure and undernutrition, which can adversely affect 
mucosal immunity.11 Pneumonia, for example, is more frequent and more severe in 
malnourished children in whom immunological studies have shown reduced cellular 
immunity, phagocyte function, complement and immunoglobulin and cytokine 
production.12,13 
 
Malnutrition, defined as the insufficient, excessive or imbalanced consumption of 
nutrients, is attributable to 53% of deaths associated with infectious diseases among 
children less than five years of age in impoverished countries.6 Malnutrition is 
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multifactorial, frequently resulting from inadequate breastfeeding, insufficient food 
availability and recurrent enteric infections.6,14 Protein-energy malnutrition manifests 
as kwashiorkor (predominantly protein deficiency) and marasmus (protein and 
energy deficiency). Micronutrient deficiency due to lack of a specific vitamin or 
mineral may coexist with these or occur in isolation.15 Acute malnutrition usually 
presents as “wasting” (a weight-to-height Z score <-2), compared with “stunting” (a 
height-to-age Z score <-2), which suggests chronic malnutrition.16 
 
Pneumococcal prevalence data could predict the potential of public health 
interventions targeting nutrition to prevent S. pneumoniae disease and/or 
transmission. The rates of colonisation in malnourished children is therefore relevant 
to interventions at the individual and population level. This systematic review and 
meta-analysis describes these rates in malnourished children under the age of 5 
years.  
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Methods 
A search of the existing literature was conducted in November 2016 to identify 
reports of URT pneumococcal colonisation rates in chronically malnourished children 
aged from 0 to 5 years. We searched PubMed (1955-2016), Medline (1950-2016), 
Scopus (1960-2016) and Web of Science (1900-2016) using combinations 
encompassing broad search strings for Streptococcus pneumoniae, nasopharyngeal 
colonisation (including carriage and carrier states) and chronic malnutrition (including 
kwashiorkor, marasmus and micronutrient deficiencies determined as per the WHO 
guidelines for the treatment of severely malnourished children).17 Specific search 
terms and their combinations are shown in Supplementary materials. 
 
Inclusion criteria were: (i) experimental or observational studies; (ii) English 
language; (iii) reporting data on URT colonisation of S. pneumoniae; (iv) subjects 
included chronically malnourished children; (v) aged 0-5 years. Studies were 
excluded which: (i) did not report rates of colonisation; (ii) were case series, case 
reports, letters or editorials. Retrieved papers were first screened by title and abstract 
then by full text. Further potential publications were identified from the reference list 
of included articles.  
 
Data were captured by pre-designed proforma. Quality and risk of bias were 
assessed using the STROBE tool.18 Prism (version 7.02, GraphPad, California USA) 
was used for statistical analysis. Studies were included in meta-analysis if they 
reported data which allowed calculation of S. pneumoniae point prevalence rates and 
if they included at least 100 participants. Pooled prevalence was calculated using a 
model which incorporated the study as a random effect and was weighted by the 
number of participants contributing data.19 
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Results 
Sixty-eight citations were identified, of which thirty-three were unique. Nine papers 
met the inclusion criteria (Figure 1). STROBE quality assessment data are given in 
Appendix 1. 
 
All studies used conventional microbiology to detect colonisation and followed 
recommendations made by the WHO for measuring nasopharyngeal colonisation.20 
Rayon-tipped swabs were the most frequently used swabs (4/9 studies, 44.4%). A 
single study from Venezuela obtained additional oropharyngeal samples.21  
 
Five studies derived from vitamin A supplementation random controlled trials (RCTs): 
two in India,22,23 one in Bangladesh,24 and two in The Gambia.25,26 One study was a 
zinc supplementation RCT in Nepal.27 Two case-control studies - one in Venezuela21, 
one in The Gambia12 - compared colonisation in malnourished children with and 
without S. pneumoniae infection. One paper was a clinical trial investigating a urinary 
pneumococcal diagnostic tool in Ecuador.28  
 
Reported prevalence of S. pneumoniae colonisation in malnourished children aged 0 
to 5 years ranged from 1.0% to 88.0% (Table 1). The prevalence rate of colonisation 
ranged from 1.0 to 2.0% at birth, increasing within the first two months of life to 
53.9% to 80.0%. Colonisation rates in the period between 3 to 60 months of life 
ranged from 64.1% and 88.0%. 
 
The pooled prevalence estimate of S. pneumoniae colonisation was 67.2% (95% CI, 
55.6%-78.7%) in children aged from 0 to ≤ 3 months, 77.9% (95% CI, 68.1%-87.7%) 
aged greater than 3 months to ≤ 6 months and 77.8% (95% CI, 73.9%-81.6%) aged 
greater than 6 months to ≤ 60 months (Figure 2). 
 
All nine papers were graded as good quality and design (Appendix 1). Control groups 
were used and appropriate in eight studies. Intervention trials used malnourished 
controls without pneumococcal infection, supplemented with placebos. The control 
group in the Gambian RCT study were provided with a lower-dose vitamin A 
supplement rather than a placebo.26 In Venezuela, matched controls of nearest-age 
siblings or cousins living in the same household were used.21  
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Discussion 
We found nasopharyngeal colonisation to be frequent in children with malnutrition 
under five years in low- and middle-income countries (53.9% to 88.0% from 2 months 
to 5 years). Pooled prevalence rates increased greatly from 1.0-2.0% at birth to 53.9-
80.0% at 2 months, reflecting the point of first acquisition of S. pneumoniae. From 3 
months up to 5 years of age, colonisation remains high between 64.1 and 88.0%. 
 
Nasopharyngeal colonisation rates amongst healthy, well-nourished children less 
than 5 years of age before the introduction of PCV have been previously reported as 
64.8% in low-income and 47.8% in lower-middle income countries.29 The prevalence 
rates found in these healthy children are lower than those found in our review of 
malnourished children. This difference may reflect clinical and methodological 
differences but suggests that prevalence rates of S. pneumoniae are higher in 
malnourished states. Our results are supported by a study in Venezuela that reported 
colonisation rates of 73% in children under 5.30 
 
Immune changes associated with protein-energy malnutrition are many: atrophic 
changes to the thymus, leading to poorly developed peripheral lymphoid organs and 
decreased T cell function and number.14 Malnutrition also reduces immunoglobulin A  
secretion, impairs complement activity and immunoglobulin responses to 
encapsulated bacteria and, indirectly, decreases phagocytic activity.31,32 In a 
persuasive case-control study, children with stunting in Venezuela were more likely 
to present with pneumococcal colonisation and acute respiratory tract infection 
compared to age-matched relatives from the same household.21 A recent study, not 
included in our review due to search time limits, found a strong association between 
stunting and S. pneumoniae colonisation.30  
 
The role of micronutrient deficiency and supplementation in acute bacterial infections 
remains controversial but zinc supplementation is effective in preventing pneumonia, 
and is recommended by the WHO.33  Suboptimal zinc status damages epithelial 
function and impairs antibody-mediated responses.27 A case-control study included in 
our systematic review found a strong interaction between zinc status and S. 
pneumoniae colonisation.27 In mice, zinc-deficiency has been associated with higher 
nasopharyngeal colonisation density of S. pneumoniae following pneumococcal 
challenge and reduced responses to PspA immunisation.33  
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Vitamin A deficiency promotes rapid bacterial colonisation in infants,34 potentially 
permitting greater bacterial adherence, colonisation, and infection.23 It is known to 
play a role in immune homeostasis as well as B- and T-cell homing to the intestinal 
mucosa.35 It is plausible that it performs a similar function at the nasal mucosa. 
Supplementation can reduce infant mortality in areas of endemic deficiency,36 
although studies examining the specific effects on bacterial colonisation are 
inconsistent. New-borns in south India dosed with vitamin A had a lower rate of 
pneumococcal colonisation at 3 months compared to those receiving placebo, but 
this was not apparent in a similar trial in Bangladesh.23,24 A third trial comparing high 
and low dose vitamin A supplementation found no difference in colonisation between 
groups.26  
 
Baseline measurements confirming micronutrient malnutrition were not 
systematically carried out within the supplementation trials22-25,26,27 and deficiency 
within the population is assumed. However, evidence of deficiency in those 
geographies was good: 17-37% of young children within the geographic area studied 
in south India had low serum retinol levels;22,23,37 the Gambian population had 
significantly lower levels than expected in the UK 38; the Bangladesh study reported a 
high prevalence of maternal night blindness, a clinical sign of vitamin A deficiency;24 
in the Nepal zinc trial 42% of children within a previous trial in the same area had low 
serum zinc concentration.27,39 
 
Our review encompassed multiple forms of macro and micronutrient malnutrition 
which, with limited data, might make pooled rates of colonisation difficult to interpret. 
The studies reported here represent a relatively limited geographic sample which 
may not represent the worldwide malnourished population. Additionally, inclusion of 
studies of malnourished children only does not allow for a detailed appraisal of the 
association between malnutrition and pneumococcal colonisation. Two studies 
combined anthropometric measurements of wasting and stunting to define their study 
population.12,21 These represent acute and chronic malnutrition respectively, and 
each may differently impact mucosal immunity and S. pneumoniae colonisation 
rates.  
 
There is not enough uniformity of reporting of vaccination within the included studies 
to comment on pneumococcal vaccination within study populations. Vaccines can 
have a profound effect on serotype prevalence,40,41 if not always overall prevalence, 
and vaccination status could be a confounding variable. 
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Other limitations of this study include bias arising from selective publication and 
methodological limitations. For example, two studies compared colonisation in 
malnourished children with and without pneumococcal infection. As colonisation is a 
prerequisite to infection, this may artificially inflate colonisation rate estimates.12,21 
Studies embedded within trials were not originally designed to deliver a cross-
sectional representation of the wider population and sampling frames may not have 
fully accounted for seasonal variation. For example, colonisation rates are higher in 
the Gambia during the dry season, perhaps due to a combination of atmospheric 
conditions which promote colonisation and increased transmission due to social 
factors such as higher school attendance (and therefore intermixing) outside of 
harvesting seasons.12,42 
 
Studies designed specifically to investigate pneumococcal colonisation in a 
malnourished population are essential for the identification of high-risk groups and to 
understand their responses to pneumococcal vaccines.  There is evidence that both 
protein-energy malnutrition and micronutrient deficiencies can affect responses to 
vaccination.43,44 The drivers of colonisation rates are complex but well-designed 
studies could be used to detect other risk factors or confounders for increased S. 
pneumoniae prevalence in the nasopharynx, including the effect on somatic growth.21 
Importantly, we do not know if colonisation produces antibody-mediated protection in 
this population as it does in healthy children.45 
 
The combination of pneumonia and malnutrition has an enormous impact on child 
mortality in developing countries. This systematic review found high prevalence of S. 
pneumoniae colonisation in malnourished children under five years of age. Although 
the available data are limited, S. pneumoniae colonisation appears more prevalent in 
this population compared to healthy children without malnutrition. Current evidence is 
insufficient to judge if correction of nutritional deficits would lead to lower colonisation 
rates.  
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Figure 1 
Flow chart showing selection of articles 
 
 
  
68 citations identified: 
 29 papers in Scopus 
 18 papers in Web of Science  
 12 papers in Medline 
 6 papers in PubMed 
12 papers excluded based on title 
and abstract  
33 screened for possible inclusion 
35 papers excluded after 
duplication 
21 full-text papers assessed for 
eligibility 
13 papers excluded in the review 
 4 reviews 
 2 letters 
 1 protocol 
 6 did not report S. 
pneumoniae colonisation 
rates  
9 papers included in the review 
(including 1 paper from references) 
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Figure 2 
Meta-analysis of S. pneumoniae carriage in malnourished children under 5 years of 
age. Children aged: (A) 0 to ≤ 3 months, (B) <3 to ≤ 6 months, (C) <6 to ≤ 60 months. 
The prevalence carriage rate for each study is represented by a square. An unfilled 
diamond represents the pooled prevalence estimate. The 95% confidence interval 
(CI) for each study is denoted by a horizontal line crossing the symbol. Weight for the 
random effects analysis for each study is given (%). 
 
 
 
 
Table 1 
Summary table of studies reporting colonisation rates of Streptococcus pneumoniae in chronically malnourished children. 
Study Study period Country Condition Population n Streptococcus pneumoniae colonisation rate (%) 
Birth 2m 3m 4m 5m 6m 12m Overall 
Coles et 
al. 200122  Oct 1998 – Jan 1999  South India  Vit A def New-borns given placebo 232 
 
54.3  67.9  69.8   
Coles et 
al. 201124 Jan 2004 –Jan 2007 Bangladesh Vit A def New-borns given placebo 225 
  
72.9      
Coles et 
al. 200123  Oct 1998 –Jun 1999 South India Vit A def Child living in area of endemic Vit A def, of which unknown proportion received VA dose  
464  53.9  64.1  70.2   
Darboe et 
al. 201025 Sept 2001 – Oct 2004 The Gambia Vit A def Child living in area of endemic Vit A def, of which unknown proportion received VA dose  
197 1.5 78.1   87.5  78.6  
Darboe et 
al. 200726 Sept 2001- Oct 2004 The Gambia Vit A def 0-12m infant receiving standard WHO Vit A dose 0-12m infant receiving high-
dose Vit A 
197 2.0 
1.0 76.0 80.0 
  
88.0 
88.0 
 
81.0 
76.0 
 
Verhagen 
et al. 
201321 
Aug 2011 Venezuela WHZ or 
HAZ <-2 Controls aged 0-10y of which 58% are acutely or chronically 
malnourished 
40        70.0 
(0-5y) 
Adegbola 
et al. 
199412 
Nov 1990- 
Oct 1992 The Gambia WFA<70% NCHS 
mean or 
oedema 
Malnourished children aged 
3m-5y without pneumonia 100 
       
72.0 
Coles et 
al. 200827 Dec 2003 – July 2004 Nepal Zn def Control groups aged 1-35m given placebo 604 
       
78.7 
Hamer et 
al. 200228 Unknown Ecuador WAZ Healthy 2-60m who were: Malnourished Mildly malnourished 
210        60.0 
72.0 
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Appendix 1 
Table of STROBE assessment of papers included in systematic review 
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Reporting Item Coles et al. 200122 Coles et al. 201124 Coles et al. 200123 
Title and Abstract 
(1) 
(a) Study design in abstract (b) 
Informative, clear abstract 
(a) Study design in abstract (b) Clear, 
balanced summary 
(a) Study design outline in abstract (b) Clear 
abstract 
Background/ratio
nale (2) 
Spn leading cause of child mortality, 
vaccines unavailable. Endemic VA def in 
areas of high Spn infection. VA may 
reduce carriage rates 
Data suggests correlation between endemic 
VA def and Spn colonisation in early 
infancy 
Region-specific data required to form 
effective vaccines as serotype prevalence 
varies temporally, geographically and by 
age. Little data in S. India 
Objectives (3) To evaluate the impact of VA on Spn NP 
colonisation in young children of endemic 
VA def 
To evaluate efficacy of new-born VA 
supplementation in preventing NP carriage 
among 3mo old infants in rural Bangladesh 
To study the epidemiology of NP 
colonisation, risk factors and distribution of 
serotypes in S. Indian infants to determine 
the effectiveness of conjugate vaccines 
Study design (4) Double-blinded, placebo case-controlled 
VA supplementation trial 
Double-blinded, placebo case-controlled VA 
supplementation trial 
Double-blinded, placebo case-controlled VA 
supplementation trial 
Settings (5) South India. Oct 1998-Jan 1999. Area of 
endemic VA def 
Bangladesh. Jan 2004- Jan 2007. Endemic 
VA def 
South India, Oct 1998-June 1999. Endemic 
VA def 
Participants (6) Carriage study from InPACT study 
embedded in VASIN trial. Eligibility 
criteria, sources, randomisation method 
and controls given 
Carriage study from JiVitA-2 embedded in 
JiVitA1 trial. Criteria given. No 
randomisation method given but refers to 
JiVitA-2 paper 
InPACT study embedded in VASIN trial. 
Have to refer VASIN trial for eligibility 
criteria and participant details 
Variables (7) All variables apart from effect modifiers 
given 
Exposures, confounding variables given but 
not clearly stated. No mention of effect 
modifiers 
Primary and additional outcomes not clear, 
exposures, confounders and effect 
modifiers not directly specified 
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Data 
sources/measure
ments (8) 
Specimen and lab procedures given Specimen and lab procedures given Specimen and lab procedures given 
Bias (9) Minimised. Use of control (selection), re-
interviewed participants at random, 
reviewed data collection forms on weekly 
basis to avoid missing data, high quality 
data collection method  
Use of controls and randomisation. 
Imbalance in sample size (VA 275 vs. 
placebo 225) reflects survival bias (survival 
until 12w old) 
No details of reducing bias 
Study size (10) Study size calculated for intervention data 
(464 required to detect 17.5% reduction in 
NP colonisation with 80% power). 
Placebo group = 232 
Used data from S. India study (Coles 2000) 
– 500 infants to detect difference of 17%. 
Placebo group = 225 
3000 embedded in VASIN trial to detect 
minimum reduction in infant mortality by 
30%. No study sample calculation for 
InPACT.  
Quantitative 
variables (11) 
Grouped according to treatment and 
placebo group 
Grouped according to treatment and 
placebo group 
Age groups split 
Statistical 
methods (12) 
(a) t test for continuous, (b) two-tailed Chi-
squared or Fisher’s for bivariate 
associations, (c) database analysed for 
missed data (d) OR used to assess 
association between risk factors and 
colonisation, (e) OR used rather than 
relative risk due to sample collection at 
2mo intervals 
(a) Chi-squared and t test for baseline (b) 
Bivariate logistic regression models (c) No 
mention of missed data (d) OR and 95%CI 
used to measure associations 
Associations tested by two-tailed chi square 
test or Fisher’s exact test. (b) Regression 
models include receipt of VA as a covariate 
(c) OR used instead of relative risk as 
prevalence rates for each age group are 
underestimate due to dynamics of 
colonisation 
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Participants (13) Number reported at each stage, non-
participation given, flow diagram given 
Number given at each stage, including non-
participants. No flow diagram 
Number at each stage given, flow chart 
given 
Descriptive data 
(14) 
(a) Table 1 for baseline data (b) number 
of participants with missing data given 
Baseline characteristics given. No 
indication of missed data 
Demographics in table 1 
Outcome data 
(15) 
Table 2 shows number in each exposure 
category 
No table given Carriage rates in text given in results 
section 
Main results (16) Unadjusted and adjusted estimates (OR) 
with p-values. Baseline, effect of VA on 
colonisation, effect of VA delaying 
colonisation, VA on invasive serotype 
colonisation, on colonisation with Ab-
resistant pneumococci 
Unadjusted and adjusted OR given. 
Multivariate models to control for effects of 
baseline and other covariates 
Carriage rates of unknown proportion 
receiving VA given. Adjusted OR given for 
risk factors of NP carriage adjusted for 
effect of VA in table 3 
Other analyses 
(17) 
None None None 
Key results (18) Summarises results, refers to objectives Summarises Summarised simply 
Limitations (19) Serum retinol levels at each interval not 
measures so VA def is assumed but good 
evidence of endemic VA def from 
previous studies in same area. Low power 
to detect differences between 2 groups 
Carriage only measured at 3mo Specimens collected at 2mo intervals so 
may underestimate true colonisation. States 
mothers suffer from night blindness but 
does not investigate if infants are VA def 
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Interpretation (20) Interprets with reference to objective, 
limitations, compares to previous similar 
studies and results 
Refers to S. Indian paper and states data 
was not significant and VA does not 
decrease colonisation. S. Indian paper data 
for 4mo. Spn colonisation dynamic process 
so may not be valid comparison. Considers 
objectives, limitations and current evidence 
Comparable data to other regions in 
developing world. Few risk factors shows to 
modify carriage 
Generalisability 
(21) 
Discusses how results may vary with 
different populations, settings and 
malnutrition setting 
When pooled with S. Indian data, new-born 
VA supplementation unlikely to decrease 
colonisation 
Cannot apply data from study population to 
a macroscopic level due to large 
socioeconomic differences  
Other information 
– funding (22) 
USAID and Institute for Sight and Life, 
John Hopkins School of Hygiene and 
Public Health 
Specimen and lab procedures given USAID and Institute for Sight and Life, John 
Hopkins School of Hygiene and Public 
Health 
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Reporting Item Darboe et al. 201025 Darboe et al. 200726 Verhagen et al. 201321 
Title and Abstract 
(1) 
(a) Study design in abstract (b) 
Informative, clear abstract 
(a) Study design in abstract (b) Clear, 
balanced summary 
(a) Study design outline in abstract (b) 
Clear abstract 
Background/ration
ale (2) 
Spn carriage highest in infancy, search for 
new vaccine is essential. Need to 
understand the distribution and dynamics 
of carriage of serotype 
Nation polices of VA supplementation in 
young children has reduced all-cause 
mortality. Higher dose thought to increase 
body stores in babies born to VA def 
mothers 
Lack of data on clinical presentations and 
aetiologies of ARTIs in indigenous people 
in South America 
Objectives (3) To study the longitudinal distribution and 
dynamics of Spn carriage of mother/infant 
pairs during a high-dose vs low-dose VA 
study 
To compare efficacy of new-born high-dose 
VA supplementation to standard low-dose 
suggested by WHO to assess side effects, 
VA concentration, mucosal integrity, growth 
and morbidity and immunity 
To investigate bacterial NP carriage, viral 
infections and nutritional status in Enepa 
Amerindian children 0-10y with and 
without ARTI and their mothers 
Study design (4) Cohort longitudinal carriage study 
embedded in double-blinded, placebo 
case-controlled VA supplementation trial 
Double-blinded, placebo case-controlled VA 
supplementation trial 
Matched-age sibling/cousin case-control 
study with and without ARTI cases and 
their mothers 
Settings (5) The Gambia. Sept 2001-Oct 2004 Bangladesh. Sept 2001 to Oct 2004 Venezuela August 2011 
Participants (6) All pregnant women in area and their 
infants unless <2200g, premature (<37w), 
congenital birth defects, severe 
peripartum difficulties 
All pregnant women in area and their 
infants unless <2200g, premature (<37w), 
congenital birth defects, severe peripartum 
difficulties 
145 children 0-10y in 5 isolated Enepa 
communities diagnosed with ARTI. 0-5y % 
malnourished given as those both acute 
(weight-for-height) and chronic (height-for-
age) combined 
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Variables (7) Outcomes outlines Primary and secondary outcomes outlined Primary and additional outcomes not 
clear, exposures, confounders and effect 
modifiers not directly specified 
Data 
sources/measurem
ents (8) 
Specimen and lab procedures given Specimen and lab procedures given, breath 
samples for H. pylori, infant urine for gut 
epithelial integrity, breast milk concentration 
Specimen and lab procedures given 
Bias (9) Randomisation in high-dose VA trial. All 
pregnant women in 6 areas enrolled at 
30w  
Randomisation in high-dose VA trial. All 
pregnant women in 6 areas enrolled at 30w 
No details of reducing bias 
Study size (10) Spn carriage expected at 80% and 
sample size of 220 calculated to detect 
18% improvement. Recruitment target of 
110 per group to allow for drop-outs 
Spn carriage expected at 80% and sample 
size of 220 calculated to detect 18% 
improvement. Recruitment target of 110 per 
group to allow for drop-outs 
No study size calculated – 40 controls and 
40 cases. Letter46: case-controls require 
calculations, so cases represent cases. 
Response47: “Post hoc power 
calculations”: Incorrect to calculate power 
calculations after study. CI are accurate 
reflection of the strength of associations 
and power  
Quantitative 
variables (11) 
Grouped according to treatment and 
placebo group and split in birth, 2, 5 and 
12mo groups 
Grouped according to treatment and 
placebo group and split in birth, 2, 5 and 
12mo groups 
Age groups split 
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Statistical methods 
(12) 
VA def and Spn carriage compared 
between group by Pearson’s Chi-squared 
test and ANOVA. Modelling used to test 
effects of treatment with adjustment for 
sex and season 
VA def and Spn carriage compared 
between group by Pearson’s Chi-squared 
test and ANOVA. Modelling used to test 
effects of treatment with adjustment for sex 
and season 
Student’s t test and non-parametric 
Wilcoxon signed rank test – univariate 
analysis. Multivariate logistic regression 
model for age, sex, nutritional status 
Participants (13) Number reported at each stage, non-
participation given, flow diagram given 
Number reported at each stage, non-
participation given, flow diagram given 
Samples taken from 79/80 children (99%). 
No reason given for missed sample, no 
flow chart 
Descriptive data 
(14) 
No demographics given in this data but 
summarised in corresponding trial paper 
in table 3 
Baseline characteristics given. No 
indication of missed data 
Characteristics in table 1. 88% cases 
malnourished, 58% controls malnourished. 
Malnourished = acute and chronic 
Outcome data (15) Carriage rates for each serotype at birth, 
2, 5 and 12mo groups 
Carriage rates for each serotype at birth, 2, 
5 and 12mo groups 
Carriage rates for cases and controls 
combined in table 2 
Main results (16) Unadjusted and adjusted estimates (OR) 
with p-values. Serotype distribution, infant 
age and sex, seasonality, relationship 
between mother and infant carriage 
Unadjusted and adjusted OR given. 
Multivariate models to control for effects of 
baseline and other covariates. No 
difference in primary outcomes for high-
dose vs low-dose 
Cases of ARTI significantly more 
malnourished compared to controls. Spn 
carriage significantly higher in 
malnourished. No statistically significant 
relationship with carriage and age. 
Other analyses (17) None No adverse events at dosing Spn carriage associated with mothers with 
lower BMIs. No association between 
mothers and children 
Key results (18) Summarises results, refers to objectives Summarises well Summarised 
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Limitations (19) Assumed VA def within population. 
Participants had been dosed with VA 
supplementation but results found no 
detectable effect on pneumococcal 
carriage – inclusion in analysis reliable. 
Infrequent swabbing, no extension to 
other family members 
Mechanism by which mortality is reduced is 
unknown. Measurement of dose that gives 
max reduction needs many large-scale 
trials but risk of adverse effects. Low dose 
used as control rather than placebo for 
ethical considerations 
Use of sibling/cousin controls may 
underestimate effect of factors relating to 
residence and household exposure, e.g. 
biomass smoke. Larger cross-sectional 
studies required to find association with 
carriage and house-hold related factors. 
Large CI due to small sample size – data 
collection difficult during rainy season and 
in rural areas 
Interpretation (20) Equilibrium and loss of colonies reached 
by 2mo. Age dependence of carriage and 
relative contribution of mother-infant 
transmission differ between vaccine and 
non-vaccine serotypes 
No evidence to support use of higher VA 
dose 
Spn carriage is high in children up to 10y 
and chronic malnutrition significantly 
associated with increased risk of Spn 
carriage – unknown if chronic malnutrition 
is a risk factor or whether Spn carriage 
affects growth leading to growth deficits 
and chronic malnutrition 
Generalisability 
(21) 
VA shown in other studies to affect 
carriage rates so data may not truly reflect 
malnourished population once dosed 
Reflects general diet disease in Sub-
Saharan Africa. Cannot be extrapolated for 
more severe VA def and study does not 
have the power to test possibility of a 
differential effect on mortality.  
Not representative of general population of 
Enepa Amerindians or other children due 
to the case-control study design  
Other information - 
funding (22) 
Unknown Summarised Integrated Microsystems for Biosensing 
and FUNDIAM 
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Reporting Item Adegbola et al. 199412 Coles et al. 200827 Hamer et al. 200228 
Title and Abstract 
(1) 
(a) Study design in abstract (b) 
Informative, clear abstract 
(a) Study design in abstract (b) Clear, 
balanced summary 
(a) Clinical trial (b) Clear abstract 
Background/ration
ale (2) 
Pneumonia and malnutrition cause of 
mortality in children in the developing 
world. Unknown aetiology of pneumonia 
in malnourished children 
Zinc def high in South Asia. Zinc def 
children prone to infections and have higher 
incidence of infections. Zinc 
supplementation reduces ALRI risk, 
unknown if this is due to reducing carriage 
Rapid urinary pneumococcal antigen test 
(Binax NOW) has excellent sensitivity and 
specificity in adults to diagnose 
pneumonia but a study has found test to 
be positive in Spn carriage in children 
Objectives (3) To study the bacteriology and virology of 
pneumonia in malnourished children in 
the Gambia compared to malnourished 
without pneumonia and well-nourished 
with and without pneumonia 
To study the effect of zinc supplementation 
on the association of Spn carriage and risk 
of ALRI 
To evaluate the Binax NOW assay test in 
healthy children aged 2-60mo in Ecuador 
to determine NP carriage on test results 
Study design (4) Case-control study – 3 control groups Matched case-control study. Population 
based, prospective. Embedded within 
NNIPS4 trial (trial evaluating zinc, iron and 
folic acid prophylaxis on morbidity, mortality 
and growth in children 1-35mo old. 
Clinical trial of healthy children aged 2-
60mo 
Settings (5) The Gambia. Nov 1990-Oct 1992 Rural Nepal, Dec 2003-July 2004 Poor urban neighbourhoods of Quito, 
Ecuador. Unknown dates 
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Participants (6) Presenting cases from outpatient for 
cases of pneumonia. Malnourished = 
WAZ<70% of NCHS mean or oedema. 
Matched-age controls to non-pneumonia 
cases. Well-nourished with pneumonia 
from ward during study period and without 
pneumonia from health centres matched 
for age 
All children <36mo in NNIPS4 trial during 
study period who met criteria for ALRI. 
Controls were matched age without ALRI in 
last 4w and living in the same area 
Healthy children aged 2-60mo living in 
study area. Excluded those with fever, 
signs of ARTI 
Variables (7) Outcomes: bacteriology and virology for 
each group. Malnourished with 
pneumonia tested for HIV. No mentions of 
predictors or effect modifiers. Malnutrition 
given but criteria for pneumonia is vague 
Outcomes: Colonisation rates in both 
groups. Exposures: zinc or placebo. 
Confounders: matched age +/- 3mo 
Outcomes: positive NP carriage and 
positive Binax NOW test result 
Data 
sources/measurem
ents (8) 
Lung aspirations, sputum collection. Lab 
procedures to examine bacteria and 
viruses given 
NP specimen collection Clean-catch midstream urine collected for 
Binax NOW test, NP swab 15 minutes 
within urine collection 
Bias (9) Recruitment bias  Not outlined 2 people read all test results to reduce 
potential variability in interpretation 
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Study size (10) Not calculated, based on availability at the 
time. 574 children meet malnourished 
criteria of which 159 had evidence of 
pneumonia – 119 randomly enrolled. 119 
well-nourished with pneumonia controls 
on ward at the time matched. 52 well-
nourished without pneumonia enrolled 
Study size calculation. Goal to enrol 440 
ALRI cases and 440 controls = 880 children 
in total. Sample size had power to detect an 
OR of 1.53 to reject null hypothesis 
Sample size calculation – 200 children 
needed to provide power level of 0.98 
(α=0.05) to detect level of increase in the 
false-positive  
Quantitative 
variables (11) 
Summarised Summarised Positive carriage determined for whole 
group and then grouped by age and WAZ 
score 
Statistical methods 
(12) 
Chi-squared or Fisher’s exact test. 
Continuous variables compared using 
Wilcoxon rank sum test. No mention of 
handling missed data or sensitivity 
analysis 
Two-tailed McNemar’s test and paired 
student’s t test to compare baseline 
characteristics. Conditional logistic 
regression model stratified by treatment 
group and adjusted for covariates 
With and without carriage who had false-
positive antigen test results compared 
using Chi-squared test. False-positive test 
results stratified by age and WAZ score. 
Logistic regression model used to assess 
association between carriage and age to 
see if age or WAZ are predictors of false-
positives 
Participants (13) Given but no flow chart given 550 cases, 550 controls NP swabs from 209 children 
Descriptive data 
(14) 
No descriptive data given other than 
forms of malnutrition (marasmus, 
kwashiorkor, hypoalbuminemia etc) 
Table 1  None 
Outcome data (15) Table 1 Table 1 and 2 Table 1 
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Main results (16) Aetiology of pneumonia and serotypes. 
NP carriage of Spn and H.influenza high 
in all groups, isotypes present irrespective 
of nutritional status 
OR for carriage and risk of ALRI. Zinc 
modifies association between carriage and 
ALRI. Strong interaction between zinc 
status and Spn carriage 
False-positives more common in carriers 
than non-carriers (21.7%v4.2%). Carriage 
highest in youngest and decreased with 
increasing age. No association between 
mildly malnourished and malnourished 
and carriage rate. No significance 
between false-positive results and WAZ 
score 
 
Other analyses (17) None Carriage data in ALRI cases who were 
symptomatic at the time for NP swab (table 
2) 
No association between WAZ score and 
intensity of Spn growth in culture 
Key results (18) Summarises results, refers to objectives Summarises well Summarised 
Limitations (19) Diagnostic technique undertaken in 
children with well-defined areas of 
pulmonary consolidation next to chest wall 
(more frequent in well-nourished children 
than malnourished children) – may give 
differing isolation rate of bacteria 
Broad definition of ALRI – not categorised 
into moderate or severe, no blood cultures 
to determine aetiology – different 
pathogens may react differently to zinc. 
Timing of swabs may not account for 
changes of Spn carriage 
Fails to identify children with recent but 
resolving ARTI. Spn antigens shed for 
weeks post pneumonia so resolved 
infection may lead to false-positives who 
did not have carriage. Also false-positives 
may occur due to test reacting with other 
streptococci species 
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Interpretation (20) Equilibrium and loss of colonies reached 
by 2mo. Age dependence of carriage and 
relative contribution of mother-infant 
transmission differ between vaccine and 
non-vaccine serotypes 
Zinc helps impede infection process rather 
than stop carriage 
Similar results as studies in China and the 
Gambia 
Generalisability 
(21) 
Only studied community acquired 
pneumonia so cannot be applied to 
hospital acquired. Can only be applied to 
developing countries with similar 
spectrum of malnutrition as the Gambia 
Zinc effect restricted to the risk of Spn-
carriage related ALRI  
Binax NOW antigen test should be used 
with caution for pneumonia diagnosis in 
young children, especially in developing 
countries where carriage rates are high 
Other information – 
funding (22) 
Unknown Unknown Unknown 
 
w=week 
mo=month 
y=year 
Spn=S.pneumoniae 
NP=nasopharyngeal 
ARTI=Acute Respiratory Tract Infection 
ALRI=Acute Lower Respiratory Infection 
VA=vitamin A 
def=deficient/deficiency 
WAZ=Weight-for-age Z score 
OR=Odds Ratio 
CI=Confidence Interval 
 
